Boyapati A, et al. High Baseline Serum IL-6 Identifies a Subgroup of Rheumatoid Arthritis Patients with Rapid Joint Damage and Clinical Progression and Predicts Increased Sarilumab Treatment Response. ACR 2018, abstract L08.
ZonMW subsidie voor effectiviteit rituximab bij systemische sclerose
dec 2023 | Sclerodermie